PixCell Medical Announces Regulatory Approval from Australian Therapeutic Goods Administration (TGA) for HemoScreen Point-of-Care Hematology Analyzer

YOKNEAM ILIT, Israel, Oct. 5, 2020 /PRNewswire/ -- PixCell Medical, innovator of rapid diagnostic solutions at the point-of-care, announced today that it has received regulatory approval from the Australian Therapeutic Goods Administration (TGA) for the HemoScreen™, PixCell's hematology analyzer that offers a 5-part differential CBC...

Read more: PixCell Medical Announces Regulatory Approval from Australian Therapeutic Goods Administration (TGA)...

More Articles …

  1. Mobilizationmagic.com Announces Kickstarter Campaign-PR Newswire APAC
  2. 244% Percent Return on Investment for Peakon Customers, Total Economic Impact Study Reveals-PR Newswire APAC
  3. Itiviti's sell-side OMS recognized for Best Equity Trading System of the Year at FOW Asia Capital Markets Awards-PR Newswire APAC
  4. Giift launches "GiiftPay"-PR Newswire APAC
  5. Nintex Announces Agreement to Acquire K2 Software, Inc.-PR Newswire APAC
  6. LTI Launches Canvas PolarSled Enabling Rapid Migration to Snowflake-PR Newswire APAC
  7. Young People Want Jobs in Innovation-first Industries; Banking and Strategic Consulting Lose Some Luster-PR Newswire APAC
  8. Technopath Clinical Diagnostics Introduces the First Unified, Purpose-Built Quality-Control (QC) Platform Providing a Higher Level of Confidence in the Precision and Accuracy of Patient Sample Results
  9. South Africa, Rossi at the service of the mining industry-PR Newswire APAC
  10. Giant Lottos Leverages Data and Machine Learning for Better Strategy When Selecting Lotto Numbers-PR Newswire APAC